Continuing a long tradition of innovation to advance treatment for cystic fibrosis (CF), University of Iowa researchers led by Paul McCray Jr., MD, were part of a team that developed a new gene editing approach to correct the most common CF-causing mutation. In collaboration with researchers at the Broad Institute of MIT and Harvard University led by David Liu, PhD, McCray and his colleagues…